Grand Rounds

Our Departmental Rounds are held every Wednesday morning from 8:00 - 10:15 am. The lectures and staff conference will be in Herbst Hall at 1600 Divisadero and the patient viewing will be held at 1701 Divisadero, unless otherwise noted on the schedule. Patient viewing begins at 8:00 am. Lecture and staff conference immediately follow, beginning at 8:40 am.

Click here if you are a PHYSICIAN who would like to bring a patient to Grand Rounds.

Click here if you are a PATIENT who is coming to Grand Rounds.

October 2016

October 5, 2016
Grand Rounds and Patient Viewing Cancelled for Resident and Faculty Retreats 

October 12, 2016
Grand Rounds and Patient Viewing
Title TBD
Kenneth Tsai, MD, PhD, Moffitt Cancer Center, Tampa, FL

October 19, 2016
Grand Rounds and Patient Viewing Cancelled for Resident Morphology Teaching

October 26, 2016
Senior Grand Rounds and Patient Viewing
Merkel Cell Carcinoma: A Review and Update on Therapy
Tiffany Tello, MD, Senior Resident, Department of Dermatology, UCSF
Clinical Conundrums in Melanoma in Situ
Drew Saylor, MD, MPH, Chief Resident, Department of Dermatology, UCSF

November 2016
December 2016

Accreditation: 

The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for continuing Medical Education to provide continuing medical education for physicians.

The UCSF School of Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credits TM    Physicians should claim only the credit commensurate with the extent of their participation in the activity.

You must sign in to qualify for CME credit.

The University of California, San Francisco Dermatology Grand Rounds is also recognized by the American Academy of Dermatology for 2 AAD Category 1 CME Credits and may be used toward the American Academy of Dermatology's Continuing Medical Education Award.

This UCSF CME educational activity was planned and developed to: uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPPA); and, include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.

This activity has been reviewed and approved by members of the UCSF CME Governing Board in accordance with UCSF CME accreditation policies. Office of CME staff, planners, reviewers, and all others in control of content have disclosed no relevant financial relationships. Any conflict of interest that may arise will be resolved in accordance with the ACCME Standards for Commercial Support.